232 related articles for article (PubMed ID: 23202936)
1. Binding of the phage display derived peptide CaIX-P1 on human colorectal carcinoma cells correlates with the expression of carbonic anhydrase IX.
Askoxylakis V; Ehemann V; Rana S; Krämer S; Rahbari NN; Debus J; Haberkorn U
Int J Mol Sci; 2012 Oct; 13(10):13030-48. PubMed ID: 23202936
[TBL] [Abstract][Full Text] [Related]
2. Optimization of a novel peptide ligand targeting human carbonic anhydrase IX.
Rana S; Nissen F; Marr A; Markert A; Altmann A; Mier W; Debus J; Haberkorn U; Askoxylakis V
PLoS One; 2012; 7(5):e38279. PubMed ID: 22693612
[TBL] [Abstract][Full Text] [Related]
3. A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology.
Askoxylakis V; Garcia-Boy R; Rana S; Krämer S; Hebling U; Mier W; Altmann A; Markert A; Debus J; Haberkorn U
PLoS One; 2010 Dec; 5(12):e15962. PubMed ID: 21209841
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.
Petrul HM; Schatz CA; Kopitz CC; Adnane L; McCabe TJ; Trail P; Ha S; Chang YS; Voznesensky A; Ranges G; Tamburini PP
Mol Cancer Ther; 2012 Feb; 11(2):340-9. PubMed ID: 22147747
[TBL] [Abstract][Full Text] [Related]
5. Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology.
Xu C; Lo A; Yammanuru A; Tallarico AS; Brady K; Murakami A; Barteneva N; Zhu Q; Marasco WA
PLoS One; 2010 Mar; 5(3):e9625. PubMed ID: 20224781
[TBL] [Abstract][Full Text] [Related]
6. Screening of a novel peptide targeting the proteoglycan-like region of human carbonic anhydrase IX.
Rana S; Nissen F; Lindner T; Altmann A; Mier W; Debus J; Haberkorn U; Askoxylakis V
Mol Imaging; 2013; 12(8):. PubMed ID: 24447616
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.
McIntyre A; Patiar S; Wigfield S; Li JL; Ledaki I; Turley H; Leek R; Snell C; Gatter K; Sly WS; Vaughan-Jones RD; Swietach P; Harris AL
Clin Cancer Res; 2012 Jun; 18(11):3100-11. PubMed ID: 22498007
[TBL] [Abstract][Full Text] [Related]
9. Targeting carbonic anhydrase IX with small organic ligands.
Wichert M; Krall N
Curr Opin Chem Biol; 2015 Jun; 26():48-54. PubMed ID: 25721398
[TBL] [Abstract][Full Text] [Related]
10. Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX.
Murri-Plesko MT; Hulikova A; Oosterwijk E; Scott AM; Zortea A; Harris AL; Ritter G; Old L; Bauer S; Swietach P; Renner C
Eur J Pharmacol; 2011 Apr; 657(1-3):173-83. PubMed ID: 21315712
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of carbonic anhydrase IX in mice with hypoxic HT29 colorectal tumor xenografts.
Carlin S; Khan N; Ku T; Longo VA; Larson SM; Smith-Jones PM
PLoS One; 2010 May; 5(5):e10857. PubMed ID: 20523727
[TBL] [Abstract][Full Text] [Related]
12. A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis.
Araste F; Ebrahimizadeh W; Rasooli I; Rajabibazl M; Mousavi Gargari SL
Biotechnol Lett; 2014 Jan; 36(1):21-8. PubMed ID: 24068505
[TBL] [Abstract][Full Text] [Related]
13. Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma.
Cheal SM; Punzalan B; Doran MG; Evans MJ; Osborne JR; Lewis JS; Zanzonico P; Larson SM
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):985-94. PubMed ID: 24604591
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
[TBL] [Abstract][Full Text] [Related]
15. Picomolar fluorescent probes for compound affinity determination to carbonic anhydrase IX expressed in live cancer cells.
Matulienė J; Žvinys G; Petrauskas V; Kvietkauskaitė A; Zakšauskas A; Shubin K; Zubrienė A; Baranauskienė L; Kačenauskaitė L; Kopanchuk S; Veiksina S; Paketurytė-Latvė V; Smirnovienė J; Juozapaitienė V; Mickevičiūtė A; Michailovienė V; Jachno J; Stravinskienė D; Sližienė A; Petrošiūtė A; Becker HM; Kazokaitė-Adomaitienė J; Yaromina A; Čapkauskaitė E; Rinken A; Dudutienė V; Dubois LJ; Matulis D
Sci Rep; 2022 Oct; 12(1):17644. PubMed ID: 36271018
[TBL] [Abstract][Full Text] [Related]
16. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo.
Chang DK; Moniz RJ; Xu Z; Sun J; Signoretti S; Zhu Q; Marasco WA
Mol Cancer; 2015 Jun; 14():119. PubMed ID: 26062742
[TBL] [Abstract][Full Text] [Related]
17. Differential CMS-Related Expression of Cell Surface Carbonic Anhydrases IX and XII in Colorectal Cancer Models-Implications for Therapy.
Rotermund A; Brandt S; Staege MS; Luetzkendorf J; Mueller LP; Mueller T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982873
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy.
Huang W; Wang K; Huang W; He Z; Zhang J; Zhang B; Xiong Z; Gillen KM; Li W; Chen F; Yang X; Zhang S; Tian J
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4427-4439. PubMed ID: 35925443
[TBL] [Abstract][Full Text] [Related]
19. Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor.
Yang X; Minn I; Rowe SP; Banerjee SR; Gorin MA; Brummet M; Lee HS; Koo SM; Sysa-Shah P; Mease RC; Nimmagadda S; Allaf ME; Pomper MG
Oncotarget; 2015 Oct; 6(32):33733-42. PubMed ID: 26418876
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.
van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM
Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
